CytoDyn has many complicated and overlapping near-term catalysts and it is difficult to keep track of them.
I stopped sharing my Catalyst Lists a while ago due to various abuses of my research, which takes a considerable amount of time and effort.
However, as there is some recent confusion about the timing of events, and as an expression of my continued contribution to this board, I am sharing my latest list.
I take absolutely no responsibility for inaccurate or omitted information.
Do not use this list, or any of my posts, as investment advice.
Potential Catalysts w/ Est. Dates 7-22-2020
- US COVID P2 Mild-Moderate Efficacy Analysis – Week of July 27
- US COVID P3 Severe-Critical DSMC Safety Review – Week of July 27
- FDA HIV Combo BLA Type A Meeting Update – Week of July 27
- US COVID P2 Mild-Moderate FDA EUA Submission – August
- US COVID P3 Severe-Critical FDA EUA Submission – August
NOTE: The FDA may demand larger Pivotal P3 trials for both M/M and S/C indications
- Samsung Biologics Shipment Update – July
- Science Advisory Board Update PR – July/August
- Mainstream Media Update – July/August
- Mexico COVID Trial Update – July/August
- UK COVID Trial Update – July/August
- Brazil COVID Trial Update – July/August
- Other Countries Express Interest in Trials – August/September
- US COVID Funding / Grants Update – August/September
- Investment Bank Update – August/September
- IncellDx Global Distribution Agreement for Companion Assays – August/September
- Worldwide Pharma (5) Partnership Discussion Update – August/September
- Pharma Partnership Discussions: Brazil, China, India, Europe, Middle East, Northern Africa – August/September
- 10k & Audited Financials Complete – August 7-14
- Small Capital Raise Before Uplist ? – August
- NASDAQ Uplist Est. Date – ~August 22
- Larger Capital Raise After Uplist ? – August/September
- HIV Combo BLA Re-submission – August/September
- US COVID PrEP Trial ? – August/September
- US COVID Long Haul Trial ?– August/September
- US BTD Cancer Meeting: mTNBC & Basket 22 – September
- Dr. Patterson Paper Peer Reviewed – ?
- Dr. Seethamraju Paper - 11-Patients – ?
- Dr. Yang Paper - 29-Patients – ?
- Dr. Agresti Paper - 4-Patients – ?
- mTNBC Trial Update – ?
- Cancer 22-Solid Tumor Basket Trial Update – ?
- MS Trial Update – ?
- NASH Trial Update – ?
- GvHD Trial Update – ?
- Alzheimer’s Trial Update – ?
- HIV PrEP Trial Update – ?
- HIV Cure Trial Update – ?
- Taiwan Cancer Basket Trial Update – ?
- US Combo HIV FDA Approval ? – ?
2020 Potential Additional Trials:
Phase 2:
- Influenza
- Stroke
- Septic Shock
- IBS Inflammatory Bowel Syndrome
- Psoriasis
- Autoimmune Hepatitis
Phase 3:
- HIV Mono Therapy
Completed Catalysts
- Dr.BP Manuscript Pre-print
- US COVID Pediatric Protocol
- NEJM Submissions Amarex Montefiore / Georgia
- US COVID Distribution Agreement
- Dr. Sacha HIV PrEP Presentation
Back-Burner Catalysts
- US COVID P3 Remdesivir 3-Arm Trial
- Dr.BP Manuscript #2 Pre-Print
- Dr.BP Manuscript #2 Peer Review
- Dr.BP Infectious Virus in Plasma Investigation
- Dr.BP Rantes Susceptibility Testing Program
- Commercialization Officer Full Time Hire
Rejected Catalysts
- US COVID Emergency eIND
- US COVID Compassionate Use Pre-July
I stopped sharing my Catalyst Lists a while ago due to various abuses of my research, which takes a considerable amount of time and effort.
However, as there is some recent confusion about the timing of events, and as an expression of my continued contribution to this board, I am sharing my latest list.
I take absolutely no responsibility for inaccurate or omitted information.
Do not use this list, or any of my posts, as investment advice.
Potential Catalysts w/ Est. Dates 7-22-2020
- US COVID P2 Mild-Moderate Efficacy Analysis – Week of July 27
- US COVID P3 Severe-Critical DSMC Safety Review – Week of July 27
- FDA HIV Combo BLA Type A Meeting Update – Week of July 27
- US COVID P2 Mild-Moderate FDA EUA Submission – August
- US COVID P3 Severe-Critical FDA EUA Submission – August
NOTE: The FDA may demand larger Pivotal P3 trials for both M/M and S/C indications
- Samsung Biologics Shipment Update – July
- Science Advisory Board Update PR – July/August
- Mainstream Media Update – July/August
- Mexico COVID Trial Update – July/August
- UK COVID Trial Update – July/August
- Brazil COVID Trial Update – July/August
- Other Countries Express Interest in Trials – August/September
- US COVID Funding / Grants Update – August/September
- Investment Bank Update – August/September
- IncellDx Global Distribution Agreement for Companion Assays – August/September
- Worldwide Pharma (5) Partnership Discussion Update – August/September
- Pharma Partnership Discussions: Brazil, China, India, Europe, Middle East, Northern Africa – August/September
- 10k & Audited Financials Complete – August 7-14
- Small Capital Raise Before Uplist ? – August
- NASDAQ Uplist Est. Date – ~August 22
- Larger Capital Raise After Uplist ? – August/September
- HIV Combo BLA Re-submission – August/September
- US COVID PrEP Trial ? – August/September
- US COVID Long Haul Trial ?– August/September
- US BTD Cancer Meeting: mTNBC & Basket 22 – September
- Dr. Patterson Paper Peer Reviewed – ?
- Dr. Seethamraju Paper - 11-Patients – ?
- Dr. Yang Paper - 29-Patients – ?
- Dr. Agresti Paper - 4-Patients – ?
- mTNBC Trial Update – ?
- Cancer 22-Solid Tumor Basket Trial Update – ?
- MS Trial Update – ?
- NASH Trial Update – ?
- GvHD Trial Update – ?
- Alzheimer’s Trial Update – ?
- HIV PrEP Trial Update – ?
- HIV Cure Trial Update – ?
- Taiwan Cancer Basket Trial Update – ?
- US Combo HIV FDA Approval ? – ?
2020 Potential Additional Trials:
Phase 2:
- Influenza
- Stroke
- Septic Shock
- IBS Inflammatory Bowel Syndrome
- Psoriasis
- Autoimmune Hepatitis
Phase 3:
- HIV Mono Therapy
Completed Catalysts
- Dr.BP Manuscript Pre-print
- US COVID Pediatric Protocol
- NEJM Submissions Amarex Montefiore / Georgia
- US COVID Distribution Agreement
- Dr. Sacha HIV PrEP Presentation
Back-Burner Catalysts
- US COVID P3 Remdesivir 3-Arm Trial
- Dr.BP Manuscript #2 Pre-Print
- Dr.BP Manuscript #2 Peer Review
- Dr.BP Infectious Virus in Plasma Investigation
- Dr.BP Rantes Susceptibility Testing Program
- Commercialization Officer Full Time Hire
Rejected Catalysts
- US COVID Emergency eIND
- US COVID Compassionate Use Pre-July
21
